Insider Stock Trader

Insider sale LGND

Ligand Pharmaceuticals Inc director Jason Aryeh trims stake with $960,141 sale

The director sold at an average of $320.05 a share, according to a Form 4 filed with the SEC on Nov 12.

A Form 4 filed on Nov 12 shows Jason Aryeh (Director) selling 3,000 Ligand Pharmaceuticals Inc shares worth about $960,000 on Nov 10.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.

The insider still holds 105,476 shares after the sale, 2.8% fewer than before. It is the seventh insider sale at Ligand Pharmaceuticals Inc reported in the last 90 days.

Details from the SEC filing:

The sale
CompanyLigand Pharmaceuticals Inc (LGND)
InsiderJason Aryeh
RoleDirector
TransactionOpen-market sale (code S)
Shares3,000
Average price$320.05
Value$960,141
Trade dateNov 10, 2026
Filed with the SECNov 12, 2026, 4:49 PM ET
Shares held after105,476
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

Read the daily insider trading roundup · Follow LGND for the next insider trade

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.